THACI, D.; GOTTLIEB, A.; REICH, K.; BAGEL, J.; BURGE, D.; PETERSON, L.; DREW, J.; ARENDT, C.; WEGLOWSKA, J. Certolizumab Pegol for the Treatment of Chronic Plaque Psoriasis: DLQI and WPAI Patient-Reported Outcomes from Two Ongoing Phase 3, Multicenter, Randomized, Placebo-Controlled Studies (CIMPASI-1 and CIMPASI-2). SKIN The Journal of Cutaneous Medicine, [S. l.], v. 1, n. 3.1, p. s4, 2017. DOI: 10.25251/skin.1.supp.3. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/126. Acesso em: 3 jul. 2024.